Vir Biotechnology reports positive hepatitis delta trial data
Go back to Vir Biotechnology reports positive hepatitis delta trial data| (NASDAQ: VIR) | Delayed: 10.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.81 | 52 Week High | $ | |||
| Open | $10.81 | 52 Week Low | $ | |||
| Day High | $10.81 | P/E | N/A | |||
| Day Low | $10.81 | EPS | $ | |||
| Volume | 42 | |||||
